OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
February 25, 2010
While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD
October 11, 2009
Oncology drug development pipelines are overflowing, but the sky-high prices of these agents are turning reimbursement schemes, and the very practice of cancer medicine, on their heads
August 22, 2009
A fast-growing market supports more, and more comprehensive, data services
June 13, 2009
Spurred by some recent successful launches, and with hefty R&D funding commitments, the vaccine business is booming
March 28, 2009
Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy